Liao C.-H.Ko W.-C.PO-REN HSUEH2020-12-182020-12-1820131058-4838https://scholars.lib.ntu.edu.tw/handle/123456789/528401[SDGs]SDG3ciprofloxacin; nalidixic acid; antibiotic resistance; bacteremia; food industry; human; letter; mycotic aneurysm; nonhuman; priority journal; Salmonella enterica; Taiwan; typhoid fever; Academic Medical Centers; Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Incidence; Salmonella enterica; Salmonella Infections; Taiwanletter10.1093/cid/cit040233900702-s2.0-84876008749